TDF therapy in pregnancy reduces HBV DNA, risk of vertical transmission

Viremic mothers treated with tenofovir disoproxil fumarate during pregnancy had decreased hepatitis B virus infection DNA levels in their blood, which reduced the infection’s DNA serum levels in infants at birth and reduced overall mother-to-child transmission, according to study data.



You may also like...